-
April 11, 2022 New Study Links Psilocybin to Lower Risk of Opioid AddictionResearchers attempt to replicate findings from a 2017 study that found classic psychedelic use conferred...
-
April 4, 2022 Oregon Psilocybin Rules ‘May Have a Negative Impact on Lower Income Individuals’The State acknowledges proposed psilocybin services rules will incur costs that "could ultimately be passed...
-
March 30, 2022 5 Most Important Psychedelic Clinical Trials in 2022Here's why we think MAPS’ second Phase 3 MDMA trial is the most important psychedelic...
-
March 25, 2022 Psychedelic Business Spotlight – March 25This week in psychedelic business news: Filament Health scores 2nd psilocybin patent; a new psychedelics...
-
March 24, 2022 Psilocybin Is Effective in Reducing Weight Gain, New Study ShowsNeonMind finds that its proprietary psilocybin has the ability to target visceral fat, effectively reducing...
-
March 21, 2022 Another Psychedelics Company Is CrashingCore One Labs appears to be following in footsteps of Mind Cure, but that doesn't...
-
March 18, 2022 Psychedelic Business Spotlight – March 18This week in psychedelic business news: A psychedelics company folds; Ketamine Wellness Centers expand; Nova...
-
March 15, 2022 Top 5 Most Influential Psychedelic StudiesWe unpack five of the most important psychedelic studies conducted in recent years as psychedelics...
-
March 11, 2022 Psychedelic Business Spotlight- March 11This week in psychedelic business news: Small Pharma prepares big DMT studies; Health Canada approves...
-
March 10, 2022 My Favorite Psychedelic Stocks: Part 1Our resident Psychedelic Investor details five companies he thinks are in strong position to win...
